Brief: Homology Medicines Presents On Design Of Trial Evaluating Its Experimental Therapy HMI-103 For PKU At American Society Of Human Genetics Meeting

Q32 Bio

27/10/2022 17:07

Oct 27 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES PRESENTS ON DESIGN OF PHEEDIT TRIAL
EVALUATING ONE-TIME NUCLEASE-FREE GENE EDITING CANDIDATE HMI-103
FOR PKU AT AMERICAN SOCIETY OF HUMAN GENETICS MEETING

Source text for Eikon:  ID:nGNXMXndq 
Further company coverage:  FIXX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))